Cardiology

New drug doesn't improve disability among stroke patients

A new drug that showed promise in animal studies and an early clinical trial didn't improve disability among stroke patients, according to late-breaking research presented at the American Stroke Association's International ...

Medical research

Study of cox-2 inhibitors could lead to new class of stroke drugs

A study, in mice, by investigators at the Stanford University School of Medicine points toward potential new therapies for stroke, the nation's third-leading cause of death and foremost single cause of severe neurological ...

Medical research

Study finds transcriptional biomarker for Huntington's disease

Huntington's disease, a devastating genetic disorder that causes degeneration of nerve cells in the brain, affects more than 15,000 Americans, and at least 150,000 are at risk of developing the disease. There is no known ...

Genetics

Autism speaks through gene expression

Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis ...

Genetics

A genetic brain disease reversed after birth

Researchers at the RIKEN Cluster for Pioneering Research (CPR) in Japan report that Kleefstra syndrome, a genetic disorder that leads to intellectual disability, can be reversed after birth in a mouse model of the disease. ...

Psychology & Psychiatry

Challenging the necessity of anti-psychotic drugs

Trials are currently underway to evaluate how the mental health and behaviour of adults with learning disabilities is affected by the gradual withdrawal of their anti-psychotic medication.

page 2 from 4